Bioncotech Therapeutics competitive analysis

Loading summary...

Explore Bioncotech Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
Aug 21, 2019Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A Polyalkyleneimine1

Latest publications and patents of Bioncotech Therapeutics New

Explore the latest publications and patents granted to Bioncotech Therapeutics, showcasing their recent innovations and technological advancements.

Last updated on: Oct 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Bioncotech Therapeutics

Aug 21, 2019Novel Pharmaceutical Composition Comprising Particles Comprising A Complex Of A Double-Stranded Polyribonucleotide And A PolyalkyleneimineOpposition Rejected

Latest PTAB cases involving Bioncotech Therapeutics

Discover the latest PTAB cases involving Bioncotech Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bioncotech Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
BIONCOTECH THERAPEUTICS - 1 - -
TARGIMMUNE THERAPEUTICS1 - - -